Eiko LifeSciences Limited Stock

Equities

NIDL

INE666Q01016

Diversified Chemicals

Delayed Bombay S.E. 02:54:30 2024-05-22 EDT 5-day change 1st Jan Change
50.76 INR +0.34% Intraday chart for Eiko LifeSciences Limited -2.01% -20.76%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 261M 3.13M 4.27M Sales 2023 191M 2.29M 3.13M Capitalization 636M 7.64M 10.43M
Net income 2022 7M 84.11K 115K Net income 2023 7M 84.11K 115K EV / Sales 2022 1.72 x
Net Debt 2022 44.1M 530K 724K Net cash position 2023 5.59M 67.15K 91.68K EV / Sales 2023 3.3 x
P/E ratio 2022
53.9 x
P/E ratio 2023
83.1 x
Employees 3
Yield 2022 *
-
Yield 2023
-
Free-Float 19.58%
More Fundamentals * Assessed data
Dynamic Chart
Eiko Lifesciences Completes Acquisition of 25% Stake in Reflux Pharmaceuticals MT
Eiko LifeSciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Eiko Lifesciences Limited Enters into Definitive Business Agreement with Vivacious Pharmatex Private Limited CI
Eiko Lifesciences Limited Approves Appointment of Company Secretary and Compliance Officer CI
Eiko LifeSciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Eiko Lifesciences Limited Announces Resignation of Nilima Burghate as Company Secretary and Compliance Officer CI
Eiko LifeSciences Limited Approves Appointment of Nilima A. Burghate as Company Secretary and Compliance Officer CI
Eiko LifeSciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Eiko LifeSciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Eiko Lifesciences Limited Announces Resignation of Avi Vijaykumar Mundecha as Company Secretary and Compliance Officer CI
Eiko Lifesciences to Acquire Minority Stake in Reflux Pharmaceuticals MT
Eiko LifeSciences Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Eiko LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Eiko Lifesciences Completes Acquisition of Minority Stake in Vivacious Pharmatex MT
Eiko LifeSciences Limited completed the acquisition of 5% interest in Vivacious Pharmatex Private Limited from existing shareholders cum Directors. CI
More news
1 day+0.34%
1 week-2.01%
Current month-7.39%
1 month-9.94%
3 months-16.42%
6 months-17.61%
Current year-20.76%
More quotes
1 week
50.00
Extreme 50
52.98
1 month
50.00
Extreme 50
59.00
Current year
48.01
Extreme 48.01
81.32
1 year
48.01
Extreme 48.01
81.32
3 years
35.25
Extreme 35.25
110.00
5 years
7.66
Extreme 7.66
110.00
10 years
7.66
Extreme 7.66
110.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 44 -
Director of Finance/CFO 32 22-02-08
Compliance Officer - 16-02-09
Members of the board TitleAgeSince
Chairman 55 13-08-25
Director/Board Member 54 -
Chief Executive Officer 44 -
More insiders
Date Price Change Volume
24-05-22 50.76 +0.34% 9 955
24-05-21 50.59 -0.57% 10,218
24-05-18 50.88 -0.49% 5,922
24-05-17 51.13 -0.53% 22,287
24-05-16 51.4 -0.77% 30,322

Delayed Quote Bombay S.E., May 22, 2024 at 02:54 am

More quotes
Eiko LifeSciences Limited is an India-based company engaged in manufacturing, processing, formulating, producing, buying, selling, and exporting specialty and fine chemicals. The Company operates through five segments: Agrochemicals, Skin Care, Cosmetics, Food Additives, and Pharmaceutical. The products manufactured by the Company are used in pharmaceutical and agrochemical industries with various end use applications including corrosion control, photographic chemicals, solvents, and corrosion inhibitors amongst others. The Company's factory is located in Badlapur, Thane District. The manufacturing facility is spread across 41,920 square meters.
More about the company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW